← Back to Events
REGULATORY 14 DAYS AWAY
Regulatory Education for
Conference on Innovative Regulatory Strategies to Advance Medical Products, covering topics like Advanced Drug Manufacturing, AI in Drug Development, FDA’s QMSR, and Digital Health Technologies.
Coverage & Analysis
🇺🇸 Latest Americas News
All news → May 5 Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas May 5 Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment May 5 CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD